Anavex Life Sciences Corp (AVXL): Dr Randi Hagerman’s 1/12/21 lecture seri...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	19
Posts	817
Boards Moderated	0
Alias Born	12/12/2016

polarbear77

Re: None

Monday, 02/08/2021 5:40:09 PM

Monday, February 08, 2021 5:40:09 PM

Dr Randi Hagerman’s 1/12/21 lecture series topic had a noticeable spotlight on 2-73:

“The need for treatments that improve mitochondrial function, such as Anavex 2-73 can make a difference for both neurodevelopmental disorders and neurodegenerative disorders including Rett syndrome, FXS, Parkinson Disease, Alzheimer Disease and FXTAS. Future new treatments for FXSD will be reviewed including genetic interventions.”

https://health.ucdavis.edu/mindinstitute/videos/images/dls/hagerman-2021-dls.pdf

And she and her colleague, Dr David Hessl from the UC Davis Mind Institute, will again speak on 3/3/21 at the Fragile-X Patient-Focused Drug Development Meeting

https://fragilex.org/wp-content/uploads/2021-03-03-NFXF-PFDD-Agenda.pdf

Reassuring to have yet another world renowned and respected CNS disease researcher supporting our 2-73 compound in ADDITIONAL difficult to treat conditions & diseases of unmet need.